WebMay 4, 2024 · Can scientists convert a super-hallucinogen into a wonder drug? WebJul 8, 2024 · An Eleusis study published in the journal Psychopharmacology in 2024 gave older adults small doses of 5 μg, 10 μg, and 20 μg of LSD every fourth day over a 21-day period to demonstrate safety. Much of the prior research on psychedelics has focused on their psychological effects, not inflammation.
Eleusis-Website/index.html at master · nicholaspai/Eleusis-Website
WebEleusis in Greek Mythology. Demeter was one of the twelve Olympian deities in Greek mythology, although her worship predated the rise of the Hellenistic religious practices. In essence though, Demeter was a highly … WebJul 12, 2024 · Eleusis is currently developing a new chemical compound, ELE-02, that resembles a long-lasting psychedelic called DOI – 2,5-Dimethoxy-4-iodoamphetamine. Eleusis hopes to deliver this DOI analog in the form of eye drops to treat diseases of the retina. “One of the first psychedelic drugs that may be approved by the FDA, if we move … boon snug silicone sippy lids on amazon
Psychedelics in the Eleusinian Mysteries of Ancient Greece
WebJan 24, 2024 · Eleusis formulated ELE-Psilo to deliver psilocin, the active ingredient in psilocybin, via IV infusions. The Merger Highlights The transaction implies a combined company enterprise value of... WebFeb 9, 2024 · Eleusis is developing ELE-Psilo — an investigational psychedelic drug candidate designed to deliver the prodrug psilocybin’s active metabolite, psilocin, by infusion. Unlike orally administered psilocybin product candidates that must be metabolized by the body to be converted to psilocin, ELE-Psilo is designed to deliver psilocin directly. boon snug straw